To test the relationship between TCF7 and miR-34a expression with prostate cancer patient survival, Kaplan-meier analysis was performed and it showed that patients with a higher TCF7 and lower miR-34a expression had a lower survival rate (Figures 4G and 4H). The gene discussed is TCF7; the disease is prostate carcinoma.